welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
- log in
George Dickson, PhD
Emeritus Professor of Molecular Cell Biology
Centre for Biomedical Sciences
Royal Holloway - University of London
Surrey, United Kingdom
George Dickson is Emeritus Professor of Molecular Cell Biology at Royal Holloway, University of London (RHUL). He has spent most of his career studying neuromuscular disease and muscle cell biology, including the first cloning of an intact dystrophin gene, the discovery of the role of cell adhesion molecules in muscle stem cell fusion, the first identification of utrophin, and the first description of exon skipping in Duchenne muscular dystrophy (DMD). He is a member of various consortiums and projects of gene therapy. He is a past President of the European Society of Gene & Cell Therapy, and a past Secretary and founder member of the British Society for Gene Therapy.
His present research includes optimisation of exon-skipping and antisense oligonucleotide formulations for DMD, inhibition of myostatin by RNA skipping and gene therapy for DMD, development of dystrophin minigenes and AAV viral vectors for treatment of DMD, direct genome correction of DMD using endonuclease-mediated genome surgery and general muscle fibre and stem cell biology.
Stanley Nelson, MDStanley F. Nelson, MD, is Professor and ...
Gene Therapy OverviewIn this brief document, we want to expla...
Mike Gait, PhDMichael Gait obtained a PhD in 1973 in C...
NCATS, FDA Co-Host Workshop on Gene Therapy for Rare Diseases“We are now at the point of translatin...
Katherine Bushby, MD, FRCPKatherine Bushby (retired) has a long-st...
Realizing the promise of gene therapy through collaboration and partnering: Pfizer’s viewGene therapy is a promising approach to ...
The emerging role of viral vectors as vehicles for DMD gene editingDuchenne muscular dystrophy (DMD) is a g...